Syntegon Acquires Telstar
Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Syntegon, a processing and packaging company, announced on June 7, 2024 that it is acquiring Telstar, an equipment manufacturer located in Barcelona, Spain. The acquisition will add liquid pharmaceutical processing to Syntegon’s portfolio, including freeze-dryers and loading and unloading systems that will enhance the company’s vial filling and isolator solutions. The expanded portfolio will allow Syntegon to provide seamless line solutions from a single source and offer additional engineers, geographic coverage, proximity, and application expertise.
“Syntegon is world market leader in liquid vial filling. With the acquisition of Telstar, we will enhance our portfolio of innovative technologies and many successful references in the market. Our customers will benefit from even more comprehensive solutions, seamless processes, and lifecycle services,” said Torsten Türling, CEO of the Syntegon Group, in a press release. “At the same time, we can jointly capture growth opportunities and expand our market presence.”
Telstar was founded in 1963 and has been part of the Azbil Corporation since 2013. The company has four production plants located in Spain, China, and the United Kingdom; six technology centers; 10 consultancy and engineering centers; and commercial offices worldwide. Syntegon, headquartered in Germany, has 39 sites in 20 countries with 6300 employees.
“Azbil has been strengthening its product capabilities, particularly in loading systems, and enhancing the overall competitiveness of Telstar since the acquisition in 2013. Now Azbil has decided to transfer Telstar to the company we consider best to further drive Telstar’s business. We are convinced that Syntegon will make the best use of the accumulated technological capabilities and products and will achieve sustainable growth,” said Kiyohiro Yamamoto, president and Group CEO of Azbil, in the release.
“For Telstar, the incorporation into the Syntegon Group represents a great opportunity to ensure stable business development and future growth. We look forward to bringing our knowledge, expertise, and high-value technologies for aseptic manufacturing to the joint portfolio and to becoming part of the Syntegon team, backed by a shared business culture,” said Jordi Puig, CEO of Telstar.
The transaction is subject to approval by regulators. “After leading the Life Science Engineering business division of Azbil during more than 11 years, Telstar also expresses its gratitude to the Japanese Corporation for their support throughout this time, during which Telstar has reached a more solid and stable structure, in addition of reinforcing innovation activity arised from solid synergies experienced in the R&D field,” Telstar stated in a press release (2).
Syntegon also announced on June 10, 2024 that its subsidiary, Pharmatech, is launching a new Modular Bioprocessing Platform (MBP) at the Achema 2024 conference. The MBP is a flexible, fully integrated automated solution that can be configured for a full range of microbial and mammalian cell culture applications.
“Its innovative, modular design allows our customers to profit from shorter lead times and lower costs, without compromising on functionality or the accustomed ‘made in Germany’ quality,” said Christian Lavarreda, global product manager at Pharmatec, in a press release (3). “Biopharmaceutical manufacturers can now turn to Syntegon for seamless, complete solutions along the entire production chain.”
References
1. Syntegon. Set for Future Growth: Syntegon Announces Acquisition of Testar. Press Release. June 7, 2024.
https://www.syntegon.com/press/set-for-further-growth-syntegon-announces-acquisition-of-telstar
2. Telstar. Telstar Starts a New Stage. Press Release. June 7, 2024.
https://www.telstar.com/en/about-telstar/news-events/news/telstar-starts-a-new-stage/
3. Syntegon. Syntegon Launches Modular Bioprocessing Platform at Achema. Press Release. June 10, 2024. https://www.syntegon.com/press/syntegon-launches-modular-bioprocessing-platform-at-achema/
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
